Terns Other Liab from 2010 to 2024
| TERN Stock | USD 7.15 0.13 1.79% |
Other Liabilities | First Reported 2010-12-31 | Previous Quarter 1.2 M | Current Value 806.7 K | Quarterly Volatility 417.4 K |
Check Terns Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Terns Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 335.7 K, Net Interest Income of 13.5 M or Interest Income of 13.5 M, as well as many indicators such as Price To Sales Ratio of 143, Dividend Yield of 0.0 or PTB Ratio of 1.72. Terns financial statements analysis is a perfect complement when working with Terns Pharmaceuticals Valuation or Volatility modules.
Terns | Other Liab |
Latest Terns Pharmaceuticals' Other Liab Growth Pattern
Below is the plot of the Other Liab of Terns Pharmaceuticals over the last few years. It is Terns Pharmaceuticals' Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Terns Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Other Liab | 10 Years Trend |
|
Other Liab |
| Timeline |
Terns Other Liab Regression Statistics
| Arithmetic Mean | 456,093 | |
| Geometric Mean | 298,140 | |
| Coefficient Of Variation | 91.51 | |
| Mean Deviation | 376,911 | |
| Median | 142,000 | |
| Standard Deviation | 417,376 | |
| Sample Variance | 174.2B | |
| Range | 1.1M | |
| R-Value | 0.85 | |
| Mean Square Error | 51.8B | |
| R-Squared | 0.72 | |
| Significance | 0.000058 | |
| Slope | 79,418 | |
| Total Sum of Squares | 2.4T |
Terns Other Liab History
About Terns Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Terns Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Terns Pharmaceuticals investors use historical funamental indicators, such as Terns Pharmaceuticals's Other Liab, to determine how well the company is positioned to perform in the future. Although Terns Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Terns Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Terns Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Terns Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Terns Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Liabilities | 1.2 M | 806.7 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Terns Stock
When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:Check out the analysis of Terns Pharmaceuticals Correlation against competitors. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.26) | Revenue Per Share 0.035 | Return On Assets (0.24) | Return On Equity (0.35) |
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.